Objective: To study the pharmacokinetics of 20(R)-Ginsenoside Rg3 in the human body. Methods: High-performance liquid chromatography-ultraviolet detection method was used in this study. Results: The pharmacokinetics o...Objective: To study the pharmacokinetics of 20(R)-Ginsenoside Rg3 in the human body. Methods: High-performance liquid chromatography-ultraviolet detection method was used in this study. Results: The pharmacokinetics of Ginsenoside Rg3 in 14 healthy volunteers were investigated. After a single oral dose of 3.2 mg.g-1 Ginsenoside Rg3 in 8 male volunteers, the plasma concentration-time course fitted in well with a two-compartment open model, with the following pharmacokinetic parameters: Tmax 0.660.10 h, Cmax 166 ngmL-1, T1/2a 0.460.12 h, T1/2b 4.91.1 h, T1/2(Ka) 0.280.04 h, AUC0-∞ 7726 ngmL-1h, respectively. No kinetic analysis was made after an oral dose of 0.8 mg.g-1 Rg3 in other 6 volunteers because of the low concentration, but there was a good correlation between Cmax and dosage of the two groups. Conclusion: The absorption of Rg3 was rapid in the human body, and its elimination was rapid too after oral administration of Ginsenoside Rg3. The pharmacokinetic results shows that it exhibited the first-order kinetic characteristics.展开更多
Objective To compare the pharmacokinetics and relative biological availability of Paracetatool orally disintegrating tablets and general tablets in healthy volunteers. Methods In a random two periods crossover study, ...Objective To compare the pharmacokinetics and relative biological availability of Paracetatool orally disintegrating tablets and general tablets in healthy volunteers. Methods In a random two periods crossover study, 19 healthy male Chinses volunteers received a single dose of Paracetamol 500mg of two formularies respectively. The plasma concentration of paracetamol was determined by HPLC method. The pharmacokinetic parameters of the two preparation and the relative biological availability of Paracetamol orally disintegrating tablets and general tablets were caculated with statistical analysis. Results The main pharmacokinetic parameters of paracetamol orally disintegrating tablets and general tablets were ( 31436. 70 ± 7062. 80 μg · h^ -1· L^-1 and (29871.40 ± 7965.04) μg · h^ -1· L^-1 for AUC0-1 (33295. 7 ±7663. 10) μg · h^ -1· L^-1 and(31845. 20 ± 8830. 83 ) μg · h^ -1· L^-1 forAUC0-1(9. 71 ±2. 78) μg/ml and(10. 36 ±3. 86) μg/mlfor Cmax; (0. 82 ±0. 45)h and (0. 74± 0.67)hforTmax;(2.90±0. 42)h and (3. 13 ±0. 67)h for T1/2ke;(0.24 ±0.04) and (0.23 ±0.04) for Ke; (4. 1481±0. 4492 ) and (4. 0771 ±0. 8131 ) for mean residence time ( MRT) , respectively. Variance analysis showed that there was significant difference in AUC0-12 and Cmax between the two preparations. Conclusion The paracetamol orally disintegrating tablets and general tablets are bioequivalent and the relative biological availability of Paracetamol orally disintegrating tablets is ( 108 ± 19) %.展开更多
Objective To study the pharmacokinetics of intravenous magnesium isoglycyrrhizinate injection in health volunteers with HPLC-UV. Methods Single doses of 2OOmg magnesium isoglycyrrhizinate were administrated to 10 heal...Objective To study the pharmacokinetics of intravenous magnesium isoglycyrrhizinate injection in health volunteers with HPLC-UV. Methods Single doses of 2OOmg magnesium isoglycyrrhizinate were administrated to 10 health volunteers by i. v. infusion. The concentrations of magnesium isoglycyrrhizinate in plasma were assayed by HPLC-UV method. The pharmacokinetic parameters of magnesium isoglycyrrhizinate injection were calculated by program 3P87. Results The main pharmacokinetic parameters of intravenous magnesium isoglycyrrhizinate were as follows: cmax ( 67. 58 ± 8. 84 ) mg/L, T1/2α ( 1.46 ± 0. 35 ) h, T1/2β ( 23. 95 ± 4. 72 ) h, Vd ( 2. 921 ± 0. 382) L, CL (0. 186 ±0. 048) L/h,k10(0. 064 ±0. 016) h^-1, AUC0-T(1015.29 ±225. 14) mg·h^-1·L^-1 ,respectively. Conclusion We have successfully used the analytical method for magnesium isoglycyrrhizinate to study its pharmacokinetical properties of health volunteers after i. v. infusion. The method is found to be simple, accurate, stable and sensitive for application in clinical pharmacokinetics study. The concentration-time plot was fitted to a two-compartment open model with first-order elimination.展开更多
This paper focuses on Beijing as the host city for the major international sporting events and its influence on the city image building of Beijing. Major international sporting events are the key channels for the exch...This paper focuses on Beijing as the host city for the major international sporting events and its influence on the city image building of Beijing. Major international sporting events are the key channels for the exchange and dissemination of information among athletes from various countries, media coverages, national and international audiences which involves interpersonal communication, organizational communication, and mass communication at all levels. At the same time, the volunteers, especially young volunteers (mostly college student volunteers) considered as the Beijing city spokesperson and also as a group of "public diplomacy ambassadors", transfer positive energy in international communication during major international sporting events. Therefore, major international sporting events held in Beijing play an irreplaceable role in the image building of the capital city of China, Beijing.展开更多
In the present study, we aimed to investigate the effect of CYP3A4* 18 genotype on the pharmacokinetics of zolpidem in healthy Chinese Hui volunteers. Blood samples were collected from volunteers for CYP3A4 genotypin...In the present study, we aimed to investigate the effect of CYP3A4* 18 genotype on the pharmacokinetics of zolpidem in healthy Chinese Hui volunteers. Blood samples were collected from volunteers for CYP3A4 genotyping using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. A pharmacokinetic study was then carried out in three groups with CYP3A4*1/*1 (n = 6), CYP3A4*1/*18 (n = 6) and CYP3A4*18/*18 (n = 6) genotypes. Plasma levels of zolpidem were determined by HPLC-FLD method before and after a single oral dose of 10 mg zolpidem tartrate tablet. Significant differences were observed in the pharmacokinetic parameters of zolpidem among the three genotype groups (P〈0.05). Compared with the CYP3A4*1/*1 group, the Cm,x of zolpidem in *1/*18 and *18/*18 groups (mean, 95% CI) was 0.89 (0.65-1.12) and 0.57 (0.47-0.66), respectively, and the AUC0-1 in the *1/*18 and *18/*18 groups (mean, 95% CI) was 0.74 (0.22-1.26) and 0.61 (0.24-0.98), respectively. There was a significant trend towards lower Cmax and AUC0-1 values of zolpidem in individuals with more CYP3A* 18 alleles, suggesting a gene-dosage effect. The study demonstrated that the CYP3A4* 18 allele played an important role in the pharmacokinetics of the zolpidem after oral administration.展开更多
文摘Objective: To study the pharmacokinetics of 20(R)-Ginsenoside Rg3 in the human body. Methods: High-performance liquid chromatography-ultraviolet detection method was used in this study. Results: The pharmacokinetics of Ginsenoside Rg3 in 14 healthy volunteers were investigated. After a single oral dose of 3.2 mg.g-1 Ginsenoside Rg3 in 8 male volunteers, the plasma concentration-time course fitted in well with a two-compartment open model, with the following pharmacokinetic parameters: Tmax 0.660.10 h, Cmax 166 ngmL-1, T1/2a 0.460.12 h, T1/2b 4.91.1 h, T1/2(Ka) 0.280.04 h, AUC0-∞ 7726 ngmL-1h, respectively. No kinetic analysis was made after an oral dose of 0.8 mg.g-1 Rg3 in other 6 volunteers because of the low concentration, but there was a good correlation between Cmax and dosage of the two groups. Conclusion: The absorption of Rg3 was rapid in the human body, and its elimination was rapid too after oral administration of Ginsenoside Rg3. The pharmacokinetic results shows that it exhibited the first-order kinetic characteristics.
文摘Objective To compare the pharmacokinetics and relative biological availability of Paracetatool orally disintegrating tablets and general tablets in healthy volunteers. Methods In a random two periods crossover study, 19 healthy male Chinses volunteers received a single dose of Paracetamol 500mg of two formularies respectively. The plasma concentration of paracetamol was determined by HPLC method. The pharmacokinetic parameters of the two preparation and the relative biological availability of Paracetamol orally disintegrating tablets and general tablets were caculated with statistical analysis. Results The main pharmacokinetic parameters of paracetamol orally disintegrating tablets and general tablets were ( 31436. 70 ± 7062. 80 μg · h^ -1· L^-1 and (29871.40 ± 7965.04) μg · h^ -1· L^-1 for AUC0-1 (33295. 7 ±7663. 10) μg · h^ -1· L^-1 and(31845. 20 ± 8830. 83 ) μg · h^ -1· L^-1 forAUC0-1(9. 71 ±2. 78) μg/ml and(10. 36 ±3. 86) μg/mlfor Cmax; (0. 82 ±0. 45)h and (0. 74± 0.67)hforTmax;(2.90±0. 42)h and (3. 13 ±0. 67)h for T1/2ke;(0.24 ±0.04) and (0.23 ±0.04) for Ke; (4. 1481±0. 4492 ) and (4. 0771 ±0. 8131 ) for mean residence time ( MRT) , respectively. Variance analysis showed that there was significant difference in AUC0-12 and Cmax between the two preparations. Conclusion The paracetamol orally disintegrating tablets and general tablets are bioequivalent and the relative biological availability of Paracetamol orally disintegrating tablets is ( 108 ± 19) %.
文摘Objective To study the pharmacokinetics of intravenous magnesium isoglycyrrhizinate injection in health volunteers with HPLC-UV. Methods Single doses of 2OOmg magnesium isoglycyrrhizinate were administrated to 10 health volunteers by i. v. infusion. The concentrations of magnesium isoglycyrrhizinate in plasma were assayed by HPLC-UV method. The pharmacokinetic parameters of magnesium isoglycyrrhizinate injection were calculated by program 3P87. Results The main pharmacokinetic parameters of intravenous magnesium isoglycyrrhizinate were as follows: cmax ( 67. 58 ± 8. 84 ) mg/L, T1/2α ( 1.46 ± 0. 35 ) h, T1/2β ( 23. 95 ± 4. 72 ) h, Vd ( 2. 921 ± 0. 382) L, CL (0. 186 ±0. 048) L/h,k10(0. 064 ±0. 016) h^-1, AUC0-T(1015.29 ±225. 14) mg·h^-1·L^-1 ,respectively. Conclusion We have successfully used the analytical method for magnesium isoglycyrrhizinate to study its pharmacokinetical properties of health volunteers after i. v. infusion. The method is found to be simple, accurate, stable and sensitive for application in clinical pharmacokinetics study. The concentration-time plot was fitted to a two-compartment open model with first-order elimination.
文摘This paper focuses on Beijing as the host city for the major international sporting events and its influence on the city image building of Beijing. Major international sporting events are the key channels for the exchange and dissemination of information among athletes from various countries, media coverages, national and international audiences which involves interpersonal communication, organizational communication, and mass communication at all levels. At the same time, the volunteers, especially young volunteers (mostly college student volunteers) considered as the Beijing city spokesperson and also as a group of "public diplomacy ambassadors", transfer positive energy in international communication during major international sporting events. Therefore, major international sporting events held in Beijing play an irreplaceable role in the image building of the capital city of China, Beijing.
基金Funds of the Chinese Army Medical Science and Technology Research"Eleventh Five-Year Plan"Project(Grant No.06G023)
文摘In the present study, we aimed to investigate the effect of CYP3A4* 18 genotype on the pharmacokinetics of zolpidem in healthy Chinese Hui volunteers. Blood samples were collected from volunteers for CYP3A4 genotyping using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. A pharmacokinetic study was then carried out in three groups with CYP3A4*1/*1 (n = 6), CYP3A4*1/*18 (n = 6) and CYP3A4*18/*18 (n = 6) genotypes. Plasma levels of zolpidem were determined by HPLC-FLD method before and after a single oral dose of 10 mg zolpidem tartrate tablet. Significant differences were observed in the pharmacokinetic parameters of zolpidem among the three genotype groups (P〈0.05). Compared with the CYP3A4*1/*1 group, the Cm,x of zolpidem in *1/*18 and *18/*18 groups (mean, 95% CI) was 0.89 (0.65-1.12) and 0.57 (0.47-0.66), respectively, and the AUC0-1 in the *1/*18 and *18/*18 groups (mean, 95% CI) was 0.74 (0.22-1.26) and 0.61 (0.24-0.98), respectively. There was a significant trend towards lower Cmax and AUC0-1 values of zolpidem in individuals with more CYP3A* 18 alleles, suggesting a gene-dosage effect. The study demonstrated that the CYP3A4* 18 allele played an important role in the pharmacokinetics of the zolpidem after oral administration.